FDA OKs new drug for 2 types of M-S

WASHINGTON, D.C. -- The FDA today approved the first drug for a severe form of multiple sclerosis.

The drug, which is called Ocrelizumab, will be sold under the name Ocrevus.

In addition to getting the OK for Primary Progressive M-S, the drug was also approved for a more common form, relapsing M-S.

The price for Ocrevus will be $65,000 - expensive, but less than the existing drug Rebif, which didn't work as well in clinical trials